Literature DB >> 24934789

Forecasting unanticipated consequences of "The Sunshine Act": mostly cloudy.

Mark J Ratain1.   

Abstract

Mesh:

Year:  2014        PMID: 24934789      PMCID: PMC4876333          DOI: 10.1200/JCO.2014.55.4592

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.

Authors:  Christopher Robertson; Susannah Rose; Aaron S Kesselheim
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

2.  Medicare, Medicaid, Children's Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2013-02-08

3.  Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugs.

Authors:  Joshua Cohen; Ashley Malins; Zainab Shahpurwala
Journal:  Health Aff (Millwood)       Date:  2013-04       Impact factor: 6.301

4.  American Society of Clinical Oncology: Policy for relationships with companies.

Authors: 
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

  4 in total
  6 in total

1.  Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.

Authors:  Deborah C Marshall; Beverly Moy; Madeleine E Jackson; Tim K Mackey; Jona A Hattangadi-Gluth
Journal:  J Natl Cancer Inst       Date:  2016-07-07       Impact factor: 13.506

2.  Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.

Authors:  Aaron P Mitchell; Aaron N Winn; Stacie B Dusetzina
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

3.  Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.

Authors:  Mohammed W Rahman; Niti U Trivedi; Peter B Bach; Aaron P Mitchell
Journal:  J Natl Compr Canc Netw       Date:  2021-12-29       Impact factor: 12.693

Review 4.  Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.

Authors:  Deborah C Marshall; Madeleine E Jackson; Jona A Hattangadi-Gluth
Journal:  Mayo Clin Proc       Date:  2016-01       Impact factor: 7.616

5.  Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.

Authors:  Aaron P Mitchell; Akriti Mishra; Pranam Dey; Michael A Curry; Niti U Trivedi; Michael Haddadin; Mohammed W Rahman; Aaron N Winn; Stacie B Dusetzina; Peter B Bach
Journal:  Oncologist       Date:  2021-05-26

6.  The relationship between the physician and pharmaceutical industry: background ethics and regulation proposals.

Authors:  Frieder Keller; Krzysztof Marczewski; Draško Pavlović
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.